S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:QDEL

QuidelOrtho - QDEL Stock Forecast, Price & News

$87.08
+1.91 (+2.24%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$84.13
$87.10
50-Day Range
$82.98
$91.46
52-Week Range
$66.88
$120.61
Volume
306,878 shs
Average Volume
513,661 shs
Market Capitalization
$5.79 billion
P/E Ratio
7.02
Dividend Yield
N/A
Price Target
$123.83

QuidelOrtho MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
42.2% Upside
$123.83 Price Target
Short Interest
Bearish
4.03% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.61
Upright™ Environmental Score
News Sentiment
0.46mentions of QuidelOrtho in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.52%
From $5.12 to $5.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

Medical Sector

174th out of 989 stocks

Diagnostic Substances Industry

4th out of 14 stocks


QDEL stock logo

About QuidelOrtho (NASDAQ:QDEL) Stock

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Stock News Headlines

Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11 (QDEL)
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
QuidelOrtho to Host Investor Day on December 13, 2022
QuidelOrtho Reports Third Quarter 2022 Financial Results
These 10 Stocks are Gaining Today - Yahoo Finance
See More Headlines
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Company Calendar

Last Earnings
11/04/2021
Today
3/24/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
7,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$123.83
High Stock Price Forecast
$173.00
Low Stock Price Forecast
$86.00
Forecasted Upside/Downside
+42.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$548.70 million
Pretax Margin
22.53%

Debt

Sales & Book Value

Annual Sales
$3.27 billion
Cash Flow
$18.45 per share
Book Value
$74.71 per share

Miscellaneous

Free Float
64,710,000
Market Cap
$5.79 billion
Optionable
Optionable
Beta
0.25

Social Links


Key Executives

  • Douglas C. BryantDouglas C. Bryant
    President, Chief Executive Officer & Director
  • Robert Joseph Bujarski
    Chief Operating Officer & Executive Vice President
  • Joseph Michael Busky
    Chief Financial Officer
  • Werner KrollWerner Kroll
    Senior Vice President-Research & Development
  • Michael S. Iskra
    Chief Commercial Officer & Executive VP













QDEL Stock - Frequently Asked Questions

Should I buy or sell QuidelOrtho stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" QDEL shares.
View QDEL analyst ratings
or view top-rated stocks.

What is QuidelOrtho's stock price forecast for 2023?

5 brokerages have issued 1-year price objectives for QuidelOrtho's shares. Their QDEL share price forecasts range from $86.00 to $173.00. On average, they expect the company's share price to reach $123.83 in the next year. This suggests a possible upside of 42.2% from the stock's current price.
View analysts price targets for QDEL
or view top-rated stocks among Wall Street analysts.

How have QDEL shares performed in 2023?

QuidelOrtho's stock was trading at $85.67 at the beginning of 2023. Since then, QDEL shares have increased by 1.6% and is now trading at $87.08.
View the best growth stocks for 2023 here
.

When is QuidelOrtho's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our QDEL earnings forecast
.

How were QuidelOrtho's earnings last quarter?

QuidelOrtho Co. (NASDAQ:QDEL) released its quarterly earnings data on Thursday, November, 4th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.52 by $1.84. The business earned $509.70 million during the quarter, compared to analysts' expectations of $344.25 million. QuidelOrtho had a net margin of 16.80% and a trailing twelve-month return on equity of 20.45%. The firm's revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the previous year, the business posted $5.68 EPS.

What guidance has QuidelOrtho issued on next quarter's earnings?

QuidelOrtho updated its FY 2023 earnings guidance on Thursday, February, 16th. The company provided earnings per share guidance of $5.00-$5.60 for the period, compared to the consensus earnings per share estimate of $5.19. The company issued revenue guidance of $2.21 billion-$2.25 billion, compared to the consensus revenue estimate of $2.80 billion.

What is Doug Bryant's approval rating as QuidelOrtho's CEO?

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

What other stocks do shareholders of QuidelOrtho own?

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is QuidelOrtho's stock symbol?

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

Who are QuidelOrtho's major shareholders?

QuidelOrtho's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (9.85%), ArrowMark Colorado Holdings LLC (4.44%), Senvest Management LLC (4.24%), Fred Alger Management LLC (1.72%), Alyeska Investment Group L.P. (1.63%) and Geode Capital Management LLC (1.28%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends
.

How do I buy shares of QuidelOrtho?

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuidelOrtho's stock price today?

One share of QDEL stock can currently be purchased for approximately $87.08.

How much money does QuidelOrtho make?

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.79 billion and generates $3.27 billion in revenue each year. The company earns $548.70 million in net income (profit) each year or $12.40 on an earnings per share basis.

How many employees does QuidelOrtho have?

The company employs 7,000 workers across the globe.

How can I contact QuidelOrtho?

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338.

This page (NASDAQ:QDEL) was last updated on 3/25/2023 by MarketBeat.com Staff